The purpose of this clinical research study is to learn if the clinical effects of combined Chinese herbal medicine with endocrine therapy is better than endocrine therapy alone in improving the quality of life and shrinking and slowing the growth of the cancer in women with breast cancer bone metastasis.
OBJECTIVES: * Evaluate the effect of the Chinese herbal medicine on relieving the bone pain for patients with breast cancer bone metastasis. * Evaluate the effect of the Chinese herbal medicine on improving the quality of life and shrinking and slowing the growth of the cancer in women with breast cancer bone metastasis. OUTLINE: This is a randomized,multicentric, placebo-controlled, double-blind study. Patients are dynamic randomized to one of two treatment arms. * Arm I:Patients receive traditional Chinese medicine(trial drugs) and endocrine therapy for 3 months. * Arm II:Patients receive placebo and endocrine therapy for 3 months. All patients will be followed up for another 3 months with the trial drugs and endocrine therapy. According to the sample size estimate:There are 296 patients (148 per treatment arm)will be collected in this trial.
Study Type
EXPANDED_ACCESS
Dietary Supplement:Experiment group: Fructus Cnidii,Psoralea Corylifolin L.，monkshood -Granules,Oral(add into the breast cancer postoperative prescription solution),A Pack(Fructus Cnidii 9g，Psoralea Corylifolin L. 15g，monkshood 9g),Bid Days,3 Periods(a month is a period),Until progression/unacceptable toxicity Breast Cancer Postoperative Prescription -Water Decoction,Oral,200ml,Bid Days,3 Periods(a month is a period),Until progression/unacceptable toxicity Dietary Supplement:Contrast Group: Breast Cancer Postoperative Prescription -Water Decoction,Oral,200ml,Bid Days,3 Periods( a month is a period),Until progression/unacceptable toxicity
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.